Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mass Spectrometry-based Immune Profiling in Peripheral Blood of Autoimmune Diseases

NCT07188285 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT07188285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07188285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mass Spectrometry-based Immune Profiling in Peripheral Blood of Autoimmune Diseases
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 25, 2025
Completion date
September 30, 2026
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, gouty arthritis (ga), healthy controls, inflammatory myopathies, osteoarthritis, psoriatic arthritis (psa), rheumatoid arthritis (ra), sjogren's syndrome, systemic lupus erthematosus, systemic sclerosis (ssc), vasculitis